WHO validates COVID-19 vaccine prototype by year end

The coronavirus vaccine prototype may be approved before the end of the year. This will allow mass production of the preparation to begin. This was stated by the assistant director general of the World Health Organization (WHO) Rainieri Guerra, as reported by Ansa agency on October 21.

“I don’t think it will be necessary to wait till 2022 for the vaccine to be available for Italians because the prototype will be approved till the end of the year”, Guerra said. According to him, for the production of the vaccine there is sufficient production capacity not only in Europe but also in India, where the WHO industrial proposals have already been received.

Three vaccines against coronavirus are currently at the stage of readiness, the documentation is being studied by regulatory pharmagencies, said the assistant head of the WHO. As he added, about 30 drugs are at an advanced stage of development.

The third phase of vaccine testing, which is being developed by the British-Swedish pharmaceutical company AstraZeneca together with scientists from Oxford University, began in the U.S. in late August, but in September the company suspended testing of the drug around the world.

The reason was that one of the UK volunteers had an unexplained disease.

On October 2 it was reported that Russia together with AstraZeneca company will produce one of vaccines against COVID-19 in Novosibirsk.

To date, two vaccines against coronavirus have been registered in Russia. The first COVID-19 vaccine in the country and in the world was registered on August 11. The drug was developed by specialists from the Gamaleya Center and named “Sputnik V”.